Logo

Venter's Vaccine Venture

Oct 07, 2010

Novartis has teamed up with J. Craig Venter's newly formed Synthetic Genomic Vaccines Inc. in an effort to accelerate the "production of seasonal and pandemic flu vaccines," the Wall Street Journal reports. According to Fierce Vaccines, the two firms have agreed to collaborate over a period of three years. Synthetic Genomic Vaccines and Novartis aim to "produce synthetic seed viruses, shaving as much as two months off the [standard] development timeline" of five to six months, Fierce Vaccines and the WSJ Health Blog report. Our sister publication GenomeWeb Daily News has more here.

Breaking News
The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.